Table 4 Baseline laboratory measurements of male participants included in the PREVAC trial (pooled for versions 2.0, 3.0, and 4.0)

 ALT (U/L)

15.5

28.9

13.8

22.3

12.8

14.5

12.3

16.0

 AST (U/L)

19.8

22.3

20.9

17.0

21.9

11.6

30.2

27.3

 Creatinine (mg/dl)

1.00

0.21

0.75

0.22

0.53

0.14

0.39

0.10

 Potassium (mmol/L)

4.2

0.4

4.3

0.4

4.2

0.4

4.3

0.5

 White blood cells (x10³/μL)

5.4

1.5

5.9

1.6

7.3

3.4

9.0

3.0

 Neutrophils (x10³/μL)

2.4

1.1

2.4

1.1

2.9

1.3

3.0

1.3

 Lymphocytes (x10³/μL)

2.2

0.7

2.5

0.7

3.2

2.5

4.6

2.1

 Eosinophils (x10³/μL)

0.30

0.55

0.39

0.50

0.54

0.81

0.43

0.53

 Monocytes (x10³/μL)

0.44

0.16

0.53

0.20

0.60

0.25

0.82

0.33

 Basophils (x10³/μL)

0.08

0.03

0.09

0.04

0.11

0.13

0.15

0.08

 Hemoglobin (g/dl)

14.2

1.5

12.9

1.5

11.6

1.2

10.4

1.3

 Hematocrit (%)

43.1

4.3

39.0

4.2

35.0

3.5

32.1

3.6

 Platelets (x10³/μL)

233.1

67.7

270.6

79.3

309.2

89.6

409.5

139.6

 Red blood cells (x10⁶/μL)

5.1

0.6

4.9

0.5

4.5

0.5

4.5

0.6

 Red cell distribution width (%)

13.1

1.4

13.4

1.6

13.7

1.5

15.4

2.1

 Mean corpuscular volume (fL)

84.8

6.7

80.4

6.3

77.2

6.0

71.5

7.4